<DOC>
	<DOCNO>NCT02470910</DOCNO>
	<brief_summary>This research study evaluate whether standard prostate MRI examination improve radiation therapy planning prostate cancer .</brief_summary>
	<brief_title>Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning</brief_title>
	<detailed_description>In research study , investigator want determine prostate radiotherapy treatment planning improve use MRI scan help doctor accurately target prostate radiation decrease radiation dose rectum , behind prostate . To , investigator create treatment plan base MRI scan compare standard treatment , currently use CT scan rather MRI . The result study help inform doctor whether beneficial routinely use MRI scan prostate radiotherapy treatment planning .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Participants must histologically confirm prostate cancer . PSA level prostate biopsy must review Brigham Women 's Hospital Dana Farber Cancer Institute support diagnosis stage IIII prostate adenocarcinoma . Candidates PSA great 20 , digital rectal exam consistent disease outside prostate ( clinical T3/T4 disease ) , Gleason score 8 great , bone scan diagnostic pelvic CT MRI exclude metastatic disease . Prostate biopsy , serum PSA measurement , indicate diagnostic imaging study must perform within 60 day date registration . Participants prior curative local treatment prostate cancer , include radiotherapy prostatectomy . A maximum 90 day systemic androgen deprivation therapy prior registration allow . Participation limit adult patient , age 18 year old . ECOG performance status ≥2 ( Karnofsky ≥60 % ) Life expectancy great 10 year . Able tolerate MRI examination . Ability understand willingness sign write informed consent document . Participants know suspected metastatic ( stage IV ) prostate cancer . Participants implanted device , prosthesis , foreign body ferromagnetic property would make ineligible undergo MRI examination . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Stage I-III prostate adenocarcinoma</keyword>
</DOC>